“…Likewise, it is remarkable that the higher MDALys concentration is reported in long-lived tissues like brain and heart which, in addition, have higher energy demands, and share identical traits to mitochondria: High lipid content, high degree of unsaturation, and high flux of mitochondrial free radical generation. During the last 30 years, this post-translational modification has also been detected in several pathological models including metabolic diseases such as chronic iron overload [87], metabolic syndrome [88], and type 2 diabetes and its complications [44,52,89,90]; in vascular diseases like atherosclerosis [50,91,92]; and in a diversity of neurodegenerative diseases such as Alzheimer's disease [34,42], Incidental Lewy Body Disease [35], Creutzfeldt-Jakob Disease [93], Pick's disease [38], Lewy Body diseases [48], familial Parkinson's disease [46], and X-adrenoleukodystrophy [94,95]. In all these cases the pathological state presented increased steady-state levels of MDALys ascribed to alteration in lipid profiles and/or oxidative stress.…”